Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Arctuvan
- Development stage
- Unknown
- Lead developer
- Klinge Biopharma
- Administration
- Oral
01
Overview
Arctuvan is a herbal medicinal product indicated for the treatment of inflammatory diseases of the urinary tract, such as cystitis. Its active ingredient is a dry extract from bear grape leaves, primarily containing arbutin. Arbutin is metabolized in the body to hydroquinone, which exerts antibacterial and antiseptic effects within the urinary tract, inhibiting the growth and killing of bacteria and fungi responsible for these infections. The product is manufactured by Klinge Pharma GmbH and is available as film-coated tablets for oral administration.
- Brand names
- Arctuvan
- Other names
- ARCTUVAN Bärentrauben FilmtablettenARCTUVAN Bearberry film-coated tabletsArctuvan Bärentraubenblätter Filmtabletten
Beyond the preview
Go deeper on Arctuvan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Arctuvan.